Clinical Trials Logo

Filter by:
NCT ID: NCT02656537 Completed - Clinical trials for Non-paroxysmal Atrial Fibrillation

EnSite™ HD Grid Catheter AF/AT Mapping Study

Start date: August 2015
Phase: N/A
Study type: Interventional

In this clinical investigation, the safety, feasibility and performance of the novel EnSite™ HD Grid Catheter mapping system for advanced high-density three-dimensional mapping will be studied in patients undergoing catheter ablation procedures for the treatment of non-paroxysmal atrial fibrillation (AF) or left atrial tachycardia (AT).

NCT ID: NCT02654171 Completed - Clinical trials for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

Viral Inhibition in Children for Treatment of RSV

VICTOR
Start date: May 27, 2016
Phase: Phase 2
Study type: Interventional

VICTOR is a randomized, double-blind, placebo-controlled, multicenter, 2-part study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and antiviral effect of single and multiple dosing of AK0529 in infants hospitalized with RSV infection.

NCT ID: NCT02653976 Completed - Clinical trials for Peripheral T-Cell Lymphoma

A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Start date: March 25, 2016
Phase: Phase 2
Study type: Interventional

This study is a phase 2 multinational, multicenter, single-arm, open-label, non-randomized study to evaluate the efficacy and safety of SP-02L monotherapy in relapsed or refractory patients with peripheral T-cell lymphoma.

NCT ID: NCT02652481 Completed - Clinical trials for Magnetic Resonance Imaging

ENABLE MRI (Magnetic Resonance Imaging)

ENABLE-MRI
Start date: January 2016
Phase: N/A
Study type: Interventional

The objective of this study is to collect data to confirm the safety and effectiveness of the Image Ready™ MR (Magnetic Resonance) Conditional Defibrillation System when used in the 1.5T (Tesla) MRI environment under the labeled Conditions of Use (Phase I). Additionally, the study will assess medically necessary MR scans according to the labeled Conditions of Use to provide real-world scanning data (Phase I and Phase II).The study also aims to demonstrate the continued ability of the ImageReady MR Conditional Defibrillation System to sense and detect ventricular fibrillation (VF) post MRI scan by collecting and analyzing data from spontaneous VF episodes, "for-cause" VF inductions, and from an optional VF induction Sub-study. .

NCT ID: NCT02648724 Completed - Clinical trials for Non Small Cell Lung Cancer

Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies

Start date: March 2016
Phase: Phase 1/Phase 2
Study type: Interventional

This is the first study to test Sym015 in humans. The primary purpose of this study is to see if Sym015 is safe and effective for patients with advanced solid tumor malignancies without available therapeutic options.

NCT ID: NCT02648425 Completed - Solid Tumor Clinical Trials

Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine

Start date: August 5, 2014
Phase: Phase 1
Study type: Interventional

This is a phase IB study to assess the safety and tolerability of ASLAN001 when given in combination with either Cisplatin and 5-Fluorouracil or Cisplatin and Capecitabine, with a view to identifying the recommended Phase II dose.

NCT ID: NCT02648204 Completed - Clinical trials for Diabetes Mellitus, Type 2

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

SUSTAIN 7
Start date: January 6, 2016
Phase: Phase 3
Study type: Interventional

This trial is conducted in Asia, Europe and the United States of America (USA). The aim of the trial is to investigate efficacy and safety of semaglutide versus dulaglutide as add-on to metformin in subjects with type 2 diabetes.

NCT ID: NCT02645500 Completed - Quality of Life Clinical Trials

Training Program and Mobile Health Message on Promoting Family Holistic Health

Start date: October 1, 2015
Phase: N/A
Study type: Interventional

In this study, the investigators would use the training workshops as a capacity build method to deliver the holistic health knowledge for the trainers and ambassadors implementing and assisting the community-based programs for the public. The investigators hypothesize that the training workshops and mobile health messages would promote the health awareness and the health of the participants. The investigators would expect the participants influence the health behavior and attitude of their family members.

NCT ID: NCT02645071 Completed - Physical Activity Clinical Trials

Brief Program in Reducing Sedentary Behavior and Promoting Physical Exercise

Start date: July 2015
Phase: N/A
Study type: Interventional

Lack of physical activity was found to be a local and worldwide issue. Most Hong Kong people are having sedentary lifestyle. Researchers show that the increase of physical activity reduces the risk of chronic diseases, and improve cardio-pulmonary functions; whereas sedentary behaviors increase the risks. For many people, the targets of the WHO physical activity guidelines are too high to be achieved. Some people are not even willing to try, despite the evidence for the protective benefits to their long term health. In response, a recent focus has been placed upon reduction of sedentary behavior. Sedentary behavior is defined as 'those activities that do not increase energy expenditure substantially above the resting level, such as sitting, lying down, or viewing TV, or simply as "too much sitting". The primary determinants of sedentary behavior are behavioral and context-based, such as TV and screen-focused behaviors in home and work environments, sitting at work, and sitting during transport. The public health leaders have called for reducing the time spent in sedentary behaviors as a possible public health priority. This study will focus on reduction of sedentary behavior and increasing physical activity in daily life. We hypothesize that the training programs would promote the health awareness of the participants.

NCT ID: NCT02644161 Completed - Stroke Clinical Trials

Can Acupuncture Treat Post-stroke Depression?

PSD2
Start date: October 2015
Phase: N/A
Study type: Interventional

An 8-week, assessor-blind, randomized controlled trial will be conducted. A total of 138 patients with post-stroke depression (PSD) will be randomly assigned to the combination acupuncture treatment (CAI) (n = 69) or least acupuncture stimulation (LAS) (n = 69) for 3 sessions per week for 8 weeks. Treatment outcomes will be measured using the 17-item Hamilton Self-Rating Depression Scale (HAMD-17), the Montgomery-Asberg Depression Rating Scale (MADRS), and Self-Rating Depression Scale (SDS) for depression symptoms; Barthel Index (BI) for physical function, the Montreal Cognitive Assessment (MoCA) for cognitive performance. The assessment will be performed at baseline and once monthly thereafter. The study will be conducted in School of Chinese Medicine Clinics, Tung Wah Hospital, Kowloon Hospital.